The relevance of miR-125a-5p as a biomarker of inferior outcome and genetic complexity was then validated in a prospective cohort of 71 consecutive untreated CD38- CLL patients with normal FISH or 13q deletion as single abnormality. The gene discussed is CD38; the disease is B-cell chronic lymphocytic leukemia.